Media & Communications, News Now!, Politics

What to expect from Facebook, Twitter and YouTube on Election Day

The sites are key conduits for communication and information. Here’s how they plan to handle the challenges facing them before, on and after Tuesday. Facebook, YouTube and Twitter were misused by Russians to inflame American voters with divisive messages before the 2016 presidential election. The companies

News Now!, Politics

Has the Court learned nothing from Bush v. Gore?

Doesn’t seem like it has. You remember the legal horror show called Bush v. Gore? The Supreme Court couldn’t possibly replicate that. But don’t underestimate the justices’ capacity for self-inflicted wounds. The sequel’s being scripted and it may be worse. Twenty years ago,

Business, Health Care

DESTINY-Breast05 head-to-head phase 3 trial of ENHERTU® versus T-DM1 initiated in patients with HER2 positive early breast cancer at high risk after neo-adjuvant therapy

TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation of DESTINY-Breast05, a global phase 3, head-to-head trial of ENHERTU® (fam-trastuzumab deruxtecan-nxki) versus ado-trastuzumab emtansine (T-DM1) as adjuvant therapy in patients with